New international consensus guidance for management of myasthenia gravis (MG) includes updated recommendations on thymectomy and the use of agents such as rituximab and eculizumab. An international panel of experts convened by the Myasthenia Gravis Foundation of America has updated its initial 2016 guidance, and the new treatment recommendations also cover MG associated with immune ...
New guidance on myasthenia gravis from international experts
By Michael Woodhead
5 Nov 2020